» Articles » PMID: 22132362

Prolactin-a Biomarker for Antipsychotic Treatment Response?

Overview
Date 2011 Dec 2
PMID 22132362
Citations 1
Authors
Affiliations
Soon will be listed here.
Citing Articles

Integrating machine learning with electronic health record data to facilitate detection of prolactin level and pharmacovigilance signals in olanzapine-treated patients.

Zhu X, Hu J, Xiao T, Huang S, Shang D, Wen Y Front Endocrinol (Lausanne). 2022; 13:1011492.

PMID: 36313772 PMC: 9606398. DOI: 10.3389/fendo.2022.1011492.

References
1.
Rey M, Schulz P, Costa C, Dick P, Tissot R . Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics. Int Clin Psychopharmacol. 1989; 4(2):95-104. DOI: 10.1097/00004850-198904000-00001. View

2.
Goodnick P, Rodriguez L, Santana O . Antipsychotics: impact on prolactin levels. Expert Opin Pharmacother. 2002; 3(10):1381-91. DOI: 10.1517/14656566.3.10.1381. View

3.
Woods S . Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry. 2003; 64(6):663-7. DOI: 10.4088/jcp.v64n0607. View

4.
Moises H, Zoega T, Gottesman I . The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia. BMC Psychiatry. 2002; 2:8. PMC: 117774. DOI: 10.1186/1471-244x-2-8. View

5.
Otani K, Kondo T, Kaneko S, Ishida M, Fukushima Y . Correlation between prolactin response and therapeutic effects of zotepine in schizophrenic patients. Int Clin Psychopharmacol. 1994; 9(4):287-9. DOI: 10.1097/00004850-199400940-00008. View